ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Superluminal Medicines, Inc.
Superluminal Medicines is seeking a Senior Software Engineer to design, build, and operate production software systems that manage experimental data and wet‑lab workflows. The role involves owning critical infrastructure for compound registration, data ingestion, and integration with scientific platforms, while collaborating directly with scientists to translate research needs into reliable technical solutions.
Superluminal Medicines is a biotechnology company accelerating drug discovery and development to deliver next‑generation small‑molecule therapeutics. Their Hyperloop™ platform combines structure‑based drug design with AI‑driven computational methods and experimental validation to identify and optimize candidates. Initially focused on GPCR targets, their pipeline emphasizes patient‑centric precision to develop treatments for cardiometabolic diseases.
Business WireAxcelead DDP and Superluminal Announce the Intent to Collaborate on Drug Discovery Targeting Specific Molecular Mechanisms, continuing a productive relationship
Jun 23, 2025
BioWorld OnlineSuperluminal joins a $1.3B deal with series A backer Lilly
Aug 14, 2025
Citeline News & InsightsLilly Obesity Deal Gives Superluminal More Shots On GPCR Goals
Aug 28, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Superluminal Medicines, Inc..
Superluminal Medicines, Inc. didn’t post a salary, so this is our estimate from similar listings.
9% below the average for this role
GlobeNewswireSuperluminal Medicines Closes $120 Million Series A Round
Sep 9, 2024
